CG: control group
- Measurements of results: main
endpoint: proportional change in the number of packages of tenoxicam, piroxicam y
diclofenac prescribed; secondary endpoint: change in the cost per prescription for all
- Intervention: the experimental group
received an evidence-based educational outreach visit; the placebo group
received information in a routine pharmaceutical session; the control group received no
information on the topic during the duration of the study.